Oncoinvent AS is a Norwegian company focused on developing innovative cancer therapies. Founded in 2010 and headquartered in Oslo, the company specializes in antibody-based therapeutics, notably Radspherin, an alpha-emitting radioactive microsphere aimed at treating metastatic cancers within body cavities. Oncoinvent applies established physical and chemical principles with novel materials to enhance medical benefits while reducing potential safety risks. Its mission is to provide effective treatment options for cancer patients through advanced pharmaceutical products that integrate cutting-edge technology and research.
Oncoinvent AS is a Norwegian company focused on developing innovative cancer therapies. Founded in 2010 and headquartered in Oslo, the company specializes in antibody-based therapeutics, notably Radspherin, an alpha-emitting radioactive microsphere aimed at treating metastatic cancers within body cavities. Oncoinvent applies established physical and chemical principles with novel materials to enhance medical benefits while reducing potential safety risks. Its mission is to provide effective treatment options for cancer patients through advanced pharmaceutical products that integrate cutting-edge technology and research.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.